This is the authors' abstract. We don't add key points for this paper.
Key Points We report longitudinal mutational analyses of 2 patients with high-risk MDS and AML experiencing spontaneous disease remissions. Both patients had persistent clonal hematopoiesis during remission, harboring all but 1 of the mutations from the initial diagnostic sample.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Grunwald et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: